Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:587194.
doi: 10.1155/2012/587194. Epub 2012 Jun 12.

Baroreflex activation therapy for the treatment of drug-resistant hypertension: new developments

Teba Alnima  1 , Peter W de Leeuw, Abraham A Kroon
Affiliations

Baroreflex activation therapy for the treatment of drug-resistant hypertension: new developments

Teba Alnima et al. Cardiol Res Pract. 2012.

Abstract

In the past few years, novel accomplishments have been obtained in carotid baroreflex activation therapy (BAT) for the treatment of resistant hypertension. In addition, this field is still evolving with promising results in the reduction of blood pressure and heart rate. This overview addresses the latest developments in BAT for the treatment of drug-resistant hypertension. Although not totally understood considering the working mechanisms of BAT, it appeared to be possible to achieve at least as much efficacy of single-sided as bilateral stimulation. Therefore unlike the first-generation Rheos system, the second-generation Barostim neo operates by unilateral baroreflex activation, using a completely different carotid electrode. Also significant improvements in several cardiac parameters have been shown by BAT in hypertensive patients, which set the basis for further research to evaluate BAT as a therapy for systolic heart failure. Yet important uncertainties need to be clarified to guarantee beneficial effects; hence not all participants seem to respond to BAT.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Barostim neo system consisting of an implantable pulse generator and a unilateral electrode. Programming is performed by a computer system, which connects to the device by wireless telemetry. Figure permission was granted by CVRx, Inc.
Figure 2
Figure 2
The implantable pulse generators of the Rheos system (on the left) and Barostim neo (on the right). Figure permission was granted by CVRx, Inc.
Figure 3
Figure 3
The carotid sinus electrodes of Rheos system (on the right) and Barostim neo (on the left). Figure permission was granted by CVRx, Inc.
Figure 4
Figure 4
Systolic blood pressure values from screening, randomized phase, and long-term follow-up of subjects participating in Pivotal Trial. SBP : systolic blood pressure; BPTru : blood pressure measuring device; SE : standard error (Used from Bakris et al. [26]).
See this image and copyright information in PMC

References

    1. Scheffers IJM, Kroon AA, Schmidli J, et al. Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. Journal of the American College of Cardiology. 2010;56(15):1254–1258. - PubMed
    1. Bisognano JD, Bakris G, Nadim MK, et al. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. Journal of the American College of Cardiology. 2011;58(7):765–773. - PubMed
    1. Dunning AJ. The Carotid Sinus Reflex. Electrostimulation of the Carotid Sinus in Angina Pectoris. Amsterdam, The Netherlands: Royal VanGorcum; 1971.
    1. Kirchheim HR. Systemic arterial baroreceptor reflexes. Physiological Reviews. 1976;56(1):100–177. - PubMed
    1. Benarroch EE. The arterial baroreflex: functional organization and involvement in neurologic disease. Neurology. 2008;71(21):1733–1738. - PubMed

LinkOut - more resources